Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III Trial-Reference-Cited by-同舟云学术

Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III Trial

Published:2014-06 Issue:6 Volume:9 Page:825-833
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Strøm Hans H.,Bremnes Roy M.,Sundstrøm Stein H.,Helbekkmo Nina,Aasebø Ulf

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. Cancer Registry N. Cancer in Norway 2009;Cancer Registry of Norway,2011

2. Delays in the diagnostic pathways for primary pulmonary carcinoma in Southern Norway;Rolke;Respir Med,2007

3. Palliative radiotherapy regimens for non-small cell lung cancer;Lester;Cochrane Database Syst Rev,2006

4. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003;Morgensztern;J Thorac Oncol,2012

5. Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy;Alexander;Int J Radiat Oncol Biol Phys,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palliative Thoracic Radiotherapy in the Era of Modern Cancer Care for NSCLC;Cancers;2024-08-29

2. Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach;International Journal of Molecular Sciences;2024-01-26

3. Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-12-19

4. Clinical benefit of pembrolizumab in treatment of first line non-small cell lung cancer: a systematic review and meta-analysis of clinical characteristics;BMC Cancer;2023-05-19

5. Diagnosis and management of patients with stage III non‑small cell lung cancer: A joint statement by the Lebanese Society of Medical Oncology and the Lebanese Pulmonary Society (Review);Oncology Letters;2023-02-06